Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse.

BACKGROUND Short-term depletion of plasma tryptophan has been shown to result in depressive relapse in patients with remission of major depression. Positron emission tomography and single photon emission computed tomography studies implicated the dorsolateral prefrontal cortex, orbitofrontal cortex, thalamus, and caudate nucleus in the pathogenesis of depression. The purpose of this study was to measure cerebral metabolic correlates of tryptophan depletion-induced depressive relapse. METHODS Patients diagnosed as having major depression (N = 21) who clinically improved with serotonin reuptake inhibitors underwent 2 test days involving tryptophan depletion or placebo, followed 6 hours later by positron emission tomography scanning with fludeoxy-glucose F18. Brain metabolism was compared in patients with (n = 7) and without (n = 14) a tryptophan depletion-induced depressive relapse. RESULTS Tryptophan depletion resulted in a decrease in brain metabolism in the middle frontal gyrus (dorsolateral prefrontal cortex), thalamus, and orbitofrontal cortex in patients with a depletion-induced depressive relapse (but not in patients without depletion-induced relapse). Decreased brain metabolism in these regions correlated with increased depressive symptoms. Baseline metabolism was increased in prefrontal and limbic regions in relapse-prone patients. CONCLUSION Specific brain regions, including the middle frontal gyrus, thalamus, and orbitofrontal cortex, may mediate the symptoms of patients with major depression.

[1]  J D Brodie,et al.  Reproducibility of Cerebral Glucose Metabolic Measurements in Resting Human Subjects , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[2]  C. Katona,et al.  Brain 5-HT2 receptors in suicide victims: violence of death, depression and effects of antidepressant treatment , 1994, Brain Research.

[3]  J C Mazziotta,et al.  Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18. , 1985, Archives of general psychiatry.

[4]  H N Wagner,et al.  Paralimbic hypoperfusion in unipolar depression. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  E. Mackenzie,et al.  Effects of dorsal raphe stimulation on cerebral glucose utilization in the anaesthetized rat , 1991, Brain Research.

[6]  V. Arango,et al.  Autoradiographic demonstration of increased serotonin 5-HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims. , 1990, Archives of general psychiatry.

[7]  Klaus P. Ebmeier,et al.  Single photon emission tomography with 99mTc-exametazime in major depression and the pattern of brain activity underlying the psychotic/neurotic continuum. , 1992, Journal of affective disorders.

[8]  D. Duverger,et al.  Influence of ascending serotonergic pathways on glucose use in the conscious rat brain. II. Effects of electrical stimulation of the rostral raphé nuclei , 1988, Brain Research.

[9]  C. Benkelfat,et al.  Mood-lowering effect of tryptophan depletion. Enhanced susceptibility in young men at genetic risk for major affective disorders. , 1994, Archives of general psychiatry.

[10]  L. DeLisi,et al.  Glucose utilization in the temporal cortex of affectively ill patients: Positron emission tomography , 1987, Biological Psychiatry.

[11]  R A Robb,et al.  Analyze: a comprehensive, operator-interactive software package for multidimensional medical image display and analysis. , 1989, Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society.

[12]  R. Post,et al.  Prefrontal cortex dysfunction in clinical depression , 1994 .

[13]  D. Charney,et al.  Serotonergic function in depression. Prolactin response to intravenous tryptophan in depressed patients and healthy subjects. , 1984, Archives of general psychiatry.

[14]  M. Buchsbaum,et al.  Effect of sleep deprivation on brain metabolism of depressed patients. , 1992, The American journal of psychiatry.

[15]  L. DeLisi,et al.  Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders. , 1984, Archives of general psychiatry.

[16]  Karl J. Friston,et al.  The anatomy of melancholia – focal abnormalities of cerebral blood flow in major depression , 1992, Psychological Medicine.

[17]  H. Mayberg,et al.  Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease , 1990, Annals of neurology.

[18]  Klaus P. Ebmeier,et al.  Short-term effects of electroconvulsive treatment on the uptake of99mTc-Exametazime into brain in major depression shown with single photon emission tomography , 1994 .

[19]  J R Moeller,et al.  Regional cerebral blood flow in mood disorders, III. Treatment and clinical response. , 1994, Archives of general psychiatry.

[20]  P. Blockx,et al.  The decreased availability of L-tryptophan in depressed females: Clinical and biological correlates , 1990, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[21]  R. Harrop,et al.  Regional cerebral glucose metabolism in identical twins , 1988, Neuropsychologia.

[22]  S. Folstein,et al.  Paralimbic frontal lobe hypometabolism in depression associated with Huntington's disease , 1992, Neurology.

[23]  L. Siever,et al.  Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. , 1989, Archives of general psychiatry.

[24]  V. Arango,et al.  Evidence for the 5-HT Hypothesis of Suicide A Review of Post-mortem Studies , 1989, British Journal of Psychiatry.

[25]  R. Salomon,et al.  Rapid serotonin depletion as a provocative challenge test for patients with major depression: relevance to antidepressant action and the neurobiology of depression. , 1991, Psychopharmacology bulletin.

[26]  J. Mann,et al.  CSF 5-HIAA and HVA concentrations in elderly depressed patients who attempted suicide. , 1990, The American journal of psychiatry.

[27]  J. Mann,et al.  Platelet and whole blood serotonin content in depressed inpatients: Correlations with acute and life-time psychopathology , 1992, Biological Psychiatry.

[28]  D. Charney,et al.  Serotonin function and depression: neuroendocrine and mood responses to intravenous L-tryptophan in depressed patients and healthy comparison subjects. , 1991, The American journal of psychiatry.

[29]  E. Perry,et al.  Postmortem Neurochemical Studies in Depression , 1986, Annals of the New York Academy of Sciences.

[30]  S. Møller,et al.  Plasma tyrosine/neutral amino acid ratio correlated with clinical response to nortriptyline in endogenously depressed patients. , 1985, Journal of affective disorders.

[31]  J R Moeller,et al.  Regional cerebral blood flow in mood disorders. I. Comparison of major depressives and normal controls at rest. , 1990, Archives of general psychiatry.

[32]  Michael E. Phelps,et al.  Error Sensitivity of Fluorodeoxyglucose Method for Measurement of Cerebral Metabolic Rate of Glucose , 1981 .

[33]  H. Hendrie,et al.  Plasma tryptophan and five other amino acids in depressed and normal subjects. , 1981, Archives of general psychiatry.

[34]  M. Reivich,et al.  THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT 1 , 1977, Journal of neurochemistry.

[35]  S. Møller,et al.  Relationship between plasma ratio of tryptophan to competing amino acids and the response to L-tryptophan treatment in endogenously depressed patients. , 1980, Journal of affective disorders.

[36]  Klaus P. Ebmeier,et al.  State changes in brain activity shown by the uptake of 99mTc-exametazime with single photon emission tomography in major depression before and after treatment. , 1993, Journal of affective disorders.

[37]  S. Pappatà,et al.  Left prefrontal glucose hypometabolism in the depressed state: a confirmation. , 1990, The American journal of psychiatry.

[38]  I. Mena,et al.  Assessment of myocardial perfusion defect size after early and delayed SPECT imaging with technetium-99m-hexakis 2-methoxyisobutyl isonitrile after stress. , 1993, Journal of Nuclear Medicine.

[39]  M E Raichle,et al.  Neuroanatomical circuits in depression: implications for treatment mechanisms. , 1992, Psychopharmacology bulletin.

[40]  Herbert Feistel,et al.  Effects of sleep deprivation on the limbic system and the frontal lobes in affective disorders: A study with Tc-99m-HMPAO SPECT , 1991, Psychiatry Research: Neuroimaging.

[41]  H. Sackeim,et al.  Brain Imaging Studies of Antidepressant Treatments , 1994 .

[42]  H. Meltzer.  Role of Serotonin in Depression a , 1990, Annals of the New York Academy of Sciences.

[43]  M S Buchsbaum,et al.  Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness. , 1986, Journal of affective disorders.

[44]  D. Charney,et al.  Neuroendocrine and behavioral effects of dietary tryptophan restriction in healthy subjects. , 1989, Life sciences.

[45]  P. Cowen,et al.  Platelet 5-HT receptor binding during depressive illness and tricyclic antidepressant treatment. , 1987, Journal of affective disorders.

[46]  G. E. Alexander,et al.  Parallel organization of functionally segregated circuits linking basal ganglia and cortex. , 1986, Annual review of neuroscience.

[47]  J R Moeller,et al.  Regional cerebral blood flow in mood disorders. II. Comparison of major depression and Alzheimer's disease. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[48]  B. Pate,et al.  Regional Cerebral Glucose Metabolism in Major Depressive Disorder * , 1990, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[49]  W. Kaschka,et al.  Increased limbic blood flow and total sleep deprivation in major depression with melancholia , 1994, Psychiatry Research: Neuroimaging.

[50]  B. McEwen,et al.  Increased serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims. , 1986, Archives of general psychiatry.

[51]  S Adler,et al.  Design and performance of POSICAM 6.5 BGO positron camera. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[52]  M. Maes,et al.  Symptom profiles of biological markers in depression: A multivariate study , 1990, Psychoneuroendocrinology.

[53]  R. Baldessarini.  Treatment of depression by altering monoamine metabolism: precursors and metabolic inhibitors. , 1984, Psychopharmacology bulletin.

[54]  T. Brewerton,et al.  Plasma -tryptophan/neutral amino acid ratio and dexamethasone suppression in depression , 1984, Psychiatry Research.

[55]  J M Links,et al.  The Influence of Biological and Technical Factors on the Variability of Global and Regional Brain Metabolism of 2-[18F]Fluoro-2-Deoxy-D-Glucose , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[56]  R. Dolan,et al.  Depression in Parkinson's disease. A positron emission study. , 1994, The British journal of psychiatry : the journal of mental science.

[57]  B. Horwitz,et al.  Brain activity during transient sadness and happiness in healthy women. , 1995, The American journal of psychiatry.

[58]  G. Aghajanian,et al.  Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. , 1990, Archives of general psychiatry.

[59]  M. Maes,et al.  The cortisol responses to 5-hydroxytryptophan, orally, in depressive inpatients. , 1987, Journal of affective disorders.

[60]  J. Mazziotta,et al.  Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls. , 1987, Archives of general psychiatry.

[61]  G. Aghajanian,et al.  Tryptophan-deficient diet and amino acid drink deplete plasma tryptophan and induce a relapse of depression in susceptible patients , 1992, Journal of Chemical Neuroanatomy.

[62]  M. Åsberg,et al.  CSF monoamine metabolites in melancholia , 1984, Acta psychiatrica Scandinavica.

[63]  M. Raichle,et al.  Neural correlates of self-induced dysphoria. , 1993, The American journal of psychiatry.

[64]  L. Baxter.  Pet Studies of Cerebral Function in Major Depression and Obsessive-CompulsiveDisorder: the Emerging Prefrontal Cortex Consensus , 1991 .

[65]  Richard A. Robb,et al.  New approach to 3-D registration of multimodality medical images by surface matching , 1992, Other Conferences.

[66]  E. Moja,et al.  Dose-response decrease in plasma tryptophan and in brain tryptophan and serotonin after tryptophan-free amino acid mixtures in rats. , 1989, Life sciences.

[67]  André Luxen,et al.  Frontal and parietal metabolic disturbances in unipolar depression , 1994, Biological Psychiatry.

[68]  M. Åsberg,et al.  "Serotonin depression"--a biochemical subgroup within the affective disorders? , 2003, Science.

[69]  J. Mazziotta,et al.  Reduction of prefrontal cortex glucose metabolism common to three types of depression. , 1989, Archives of general psychiatry.

[70]  Sylvain Houle,et al.  Modulation of cortical neuronal activity by a serotonergic agent: a PET study in humans , 1994, Brain Research.

[71]  R. Priest.  Editor's Preface: Antidepressants of the Future , 1989, British Journal of Psychiatry.

[72]  G. Biggio,et al.  Rapid depletion of serum tryptophan, brain tryptophan, serotonin and 5-hydroxyindoleacetic acid by a tryptophan-free diet. , 1974, Life sciences.

[73]  S. Møller,et al.  Tryptophan and tyrosine ratios to neutral amino acids in endogenous depression. Relation to antidepressant response to amitriptyline and lithium + L-tryptophan. , 1983, Journal of affective disorders.

[74]  C. Nemeroff,et al.  Neurochemical alterations of serotonergic neuronal systems in depression. , 1992, The Journal of clinical psychiatry.

[75]  K J Kearfott,et al.  Quantitation of regional cerebral glucose metabolism. , 1983, Journal of computer assisted tomography.

[76]  R. Salomon,et al.  Serotonin and the neurobiology of depression. Effects of tryptophan depletion in drug-free depressed patients. , 1994, Archives of general psychiatry.